The Antidote to Poison Pills?

By Gene Marbach

The boards of companies contemplating instituting or renewing shareholder rights plans (aka “poison pills”) without seeking shareholder approval need to tread carefully in 2010. The highly influential proxy advisory firm RiskMetrics Group has released an update to its proxy voting recommendation guidelines for 2010 increasing the frequency with which RiskMetrics will recommend a vote against directors for adopting or renewing most non-shareholder approved rights plans...

Read more